直觉外科：业绩超预期新产品放量巩固市场竞争力

中金公司2025-02-06

2024 年业绩超我们预期公司公布2024 年业绩：收入83.5 亿美元（+17.2% YoY），归母净利润23.2 亿美元（+29.2% YoY），业绩超我们预期，主要因最新一代产品daVinci 5 放量超预期带动。发展趋势新产品放量带动设备板块高增长。2024 年，公司设备系统（system）板块实现收入19.7 亿美元（+17.0% YoY）。截至2024 年底，公司达芬奇手术机器人系统...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2509299590?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-06 00:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2509299590","market":"us","top_or_hot":-1,"title":"直觉外科：业绩超预期 新产品放量巩固市场竞争力","media":"中金公司","content":"<div>\n<p>2024 年业绩超我们预期公司公布2024 年业绩：收入83.5 亿美元（+17.2% YoY），归母净利润23.2 亿美元（+29.2% YoY），业绩超我们预期，主要因最新一代产品daVinci 5 放量超预期带动。发展趋势新产品放量带动设备板块高增长。2024 年，公司设备系统（system）板块实现收入19.7 亿美元（+17.0% YoY）。截至2024 年底，公司达芬奇手术机器人系统...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206110626a23b1fb2&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>直觉外科：业绩超预期 新产品放量巩固市场竞争力</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n直觉外科：业绩超预期 新产品放量巩固市场竞争力\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-06 00:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206110626a23b1fb2&s=b><strong>中金公司</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2024 年业绩超我们预期公司公布2024 年业绩：收入83.5 亿美元（+17.2% YoY），归母净利润23.2 亿美元（+29.2% YoY），业绩超我们预期，主要因最新一代产品daVinci 5 放量超预期带动。发展趋势新产品放量带动设备板块高增长。2024 年，公司设备系统（system）板块实现收入19.7 亿美元（+17.0% YoY）。截至2024 年底，公司达芬奇手术机器人系统...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206110626a23b1fb2&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2112291526.USD","symbol_name":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206110626a23b1fb2&s=b","article_id":"2509299590","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206110626a23b1fb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2509299590","pubTimestamp":1738771200,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"截至2024 年底，公司达芬奇手术机器人系统累计装机量达9902 台，年内新增装机1526 台，其中最新一代产品da Vinci 5 在1Q24 末获FDA 批准上市，年内装机359 台，带动设备板块迎来快速增长，而公司市场竞争力亦得以维系。工具及耗材（I&A）板块2024 年实现收入50.8亿美元，年内达芬奇手术机器人全球参与手术量约268.3 万例，手术量稳健爬升带动耗材产品持续迎来销售放量。风险上行催化：新款产品dV5 市场需求超预期。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU0097036916.USD":"贝莱德美国增长A2 USD","BK4585":"ETF&股票定投概念","LU1868836591.USD":"CT (LUX) I AMERICAN \"1U\"(USD) ACC","BK4534":"瑞士信贷持仓","LU0882574055.USD":"富达全球健康医疗A ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","LU1951198990.SGD":"Natixis Thematics AI & Robotics Fund H-R/A SGD-H","LU0058720904.USD":"联博国际健康护理基金A","IE00B19Z9505.USD":"美盛-美国大盘成长股A Acc","ISRG":"直觉外科公司","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","BK4082":"医疗保健设备","LU1951200564.SGD":"Natixis Thematics AI & Robotics Fund R/A SGD","BK4504":"桥水持仓","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","IE00BYQQ9H92.USD":"BNY MELLON GLOBAL LEADERS \"A\" (USD) ACC","BK4588":"碎股","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4548":"巴美列捷福持仓","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","LU1868836914.USD":"CT (LUX) I AMERICAN \"3\" (USD) ACC","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LU1923623000.USD":"Natixis Thematics AI & Robotics Fund R/A USD","LU2023250843.SGD":"Allianz Thematica Cl AT Acc H2-SGD","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1917777945.USD":"安联专题基金Cl AT Acc","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","IE00B5TLWC47.USD":"BNY MELLON LONG-TERM GLOBAL EQUITY \"B\" (USD) ACC","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","IE00B19Z8X17.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH  \"AG\" (USD) ACC","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU0079474960.USD":"联博美国增长基金A","IE00B19Z8W00.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH \"A\" INC","LU1868836757.USD":"CT (LUX) I AMERICAN FUND \"2\" (USD) ACC","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC"},"translate_title":"Intuitive Surgery: Performance exceeds expectations, new products increase in volume to consolidate market competitiveness","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ISRG":1},"content_text":"2024 年业绩超我们预期公司公布2024 年业绩：收入83.5 亿美元（+17.2% YoY），归母净利润23.2 亿美元（+29.2% YoY），业绩超我们预期，主要因最新一代产品daVinci 5 放量超预期带动。发展趋势新产品放量带动设备板块高增长。2024 年，公司设备系统（system）板块实现收入19.7 亿美元（+17.0% YoY）。截至2024 年底，公司达芬奇手术机器人系统累计装机量达9902 台，年内新增装机1526 台，其中最新一代产品da Vinci 5 在1Q24 末获FDA 批准上市，年内装机359 台，带动设备板块迎来快速增长，而公司市场竞争力亦得以维系。耗材及服务板块稳健增长。工具及耗材（I&A）板块2024 年实现收入50.8亿美元（+18.8% YoY），年内达芬奇手术机器人全球参与手术量约268.3 万例（+17.4% YoY），手术量稳健爬升带动耗材产品持续迎来销售放量。根据公开业绩电话会，公司指引2025 年手术量增速约13-16%。公司2024 年服务收入13.1 亿美元（+11.9% YoY），整体跟随设备销售实现平稳增长。利润端表现整体强劲。公司实现2024 年毛利率67.5%（+1.1pct YoY），non-GAAP 毛利率约69.1%，同时公司公开业绩会指引2025 年non-GAAP毛利率约67-68%，2025 年毛利率有所波动主要考虑到产品结构变化及汇率波动影响。公司2024 年实现归母净利率27.8%（+2.6pct YoY），利润端整体表现强劲。盈利预测与估值考虑到公司新产品放量超预期，我们上调2025 年盈利预测5.1%至24.7 亿美元，首次引入2026 年盈利预测28.6 亿美元。考虑到公司基本面持续兑现，我们上调目标价6%至582 美元（基于DCF 估值），较当前收盘价有0.4%上行空间，但考虑到当前股价或已部分打入基本面兑现预期，维持中性评级。风险上行催化：新款产品dV5 市场需求超预期。下行风险：市场竞争加剧；产品研发不顺；海外商业化进展不顺；应用拓展慢于预期。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2509299590","isCrawlerRequest":true}

直觉外科：业绩超预期 新产品放量巩固市场竞争力

精彩评论

直觉外科：业绩超预期新产品放量巩固市场竞争力